학술논문

A Phase II Study of the Sequential Combination of Low-Intensity Chemotherapy (mini-hyper-CVD) and Ponatinib Followed By Blinatumomab and Ponatinib in Patients with Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)
Document Type
Abstract
Source
In Blood 15 November 2022 140 Supplement 1:6127-6129
Subject
Language
ISSN
0006-4971